Evolution of the Average Target: Sanofi

Data source: Sanofi(SAN)
Evolution of the Average Target - Sanofi

Evolution of the Target Price: Sanofi

Data source: Sanofi(SAN)
Evolution of the Target Price - Sanofi

Changes in Analyst Recommendations: Sanofi

Data source: Sanofi(SAN)
4e04a8c80a369666eee57.9ILiemgmND5xNoIs-JhvXqpmj33kjd9PanHU0JG9eHg.zLqLDTJeYgdJD81qre0YDdBL7B7d-e1iNTegkffVPhycy4UlWnxVTj5d2w~29f47acb0cd99c7352cc2eeb534791f1
16/10 RBC Cuts Price Target on Sanofi to EUR75 From EUR80, Keeps Sector Perform Rating MT
16/10 Sanofi : Gets a Neutral rating from RBC ZD
15/10 Sanofi : UBS sticks Neutral ZD
13/10 Nurix Therapeutics' Enterprise Value Remains Underappreciated, RBC Capital Markets Says MT
07/10 Sanofi : Jefferies keeps its Buy rating ZD
07/10 Sanofi : JP Morgan sticks Neutral ZD
07/10 Berenberg Says Sanofi, Regeneron's Expanded Immunology Collaboration Extends 'Dominance' in Atopic Diseases MT
06/10 Sanofi : Berenberg remains its Buy rating ZD
01/10 Sanofi : RBC sticks Neutral ZD
01/10 Sanofi : JP Morgan reiterates its Neutral rating ZD
01/10 Sanofi to invest up to $8bn to expand alliance with Regeneron Zonebourse
01/10 Sanofi : Buy rating from Jefferies ZD
29/09 Regeneron Needs 'Better' Terms in Sanofi Renegotiation, RBC Says MT
29/09 Sanofi : Buy rating from Deutsche Bank ZD
17/09 Sanofi : UBS reiterates its Neutral rating ZD
15/09 Sanofi : Deutsche Bank reiterates its Buy rating ZD
14/09 Sanofi : Deutsche Bank reiterates its Buy rating ZD
09/09 RBC Capital Markets Begins Sanofi's Coverage at Sector Perform MT
09/09 RBC Initiates Sanofi at Sector Perform With EUR80 Price Target MT
09/09 RBC Launches Sanofi Coverage at Sector Perform Amid Management Turnaround, 'Light' Near-term Catalysts MT
09/09 Sanofi : From a Buy to Neutral rating by RBC ZD
08/09 Sanofi : Barclays is Neutral ZD
02/09 Sanofi : Gets a Buy rating from Deutsche Bank ZD
01/09 Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says MT
25/08 Sanofi : Deutsche Bank reiterates its Buy rating ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+5.65%
+9.33%
-0.99%
-0.52%
+8.56%
-0.8%
+26.78%
-8.67%
+2.34%
Average +4.63%
Weighted average by Cap. +4.96%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
71.94EUR
Average target price
93.35EUR
Spread / Average Target
+29.76%
High Price Target
107.20EUR
Spread / Highest target
+49.01%
Low Price Target
75.00EUR
Spread / Lowest Target
+4.25%

Analyst Consensus Detail

Analyst consensus - Sanofi

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Sanofi
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Sanofi